These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2393301)

  • 1. Thiol containing compounds and amino acid hydroxamates as reversible synthetic inhibitors of Astacus protease.
    Wolz RL; Zeggaf C; Stöcker W; Zwilling R
    Arch Biochem Biophys; 1990 Sep; 281(2):275-81. PubMed ID: 2393301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of leucine aminopeptidase by amino acid hydroxamates.
    Chan WW; Dennis P; Demmer W; Brand K
    J Biol Chem; 1982 Jul; 257(14):7955-7. PubMed ID: 7085655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
    Grams F; Reinemer P; Powers JC; Kleine T; Pieper M; Tschesche H; Huber R; Bode W
    Eur J Biochem; 1995 Mar; 228(3):830-41. PubMed ID: 7737183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the active site of human multicatalytic proteinase.
    Mason RW
    Biochem J; 1990 Jan; 265(2):479-84. PubMed ID: 2302179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxamate-induced spectral perturbations of cobalt Aeromonas aminopeptidase.
    Wilkes SH; Prescott JM
    J Biol Chem; 1987 Jun; 262(18):8621-5. PubMed ID: 3597389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates.
    Forbes LV; Sjögren T; Auchère F; Jenkins DW; Thong B; Laughton D; Hemsley P; Pairaudeau G; Turner R; Eriksson H; Unitt JF; Kettle AJ
    J Biol Chem; 2013 Dec; 288(51):36636-47. PubMed ID: 24194519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative QSAR study on carbonic anhydrase and matrix metalloproteinase inhibition by sulfonylated amino acid hydroxamates.
    Gupta SP; Maheswaran V; Pande V; Kumar D
    J Enzyme Inhib Med Chem; 2003 Feb; 18(1):7-13. PubMed ID: 12751815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiol versus hydroxamate as zinc binding group in HDAC inhibition: An ab initio QM/MM molecular dynamics study.
    Gong W; Wu R; Zhang Y
    J Comput Chem; 2015 Nov; 36(30):2228-35. PubMed ID: 26452222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of enkephalin-degrading enzymes from rat brain and of thermolysin by amino acid hydroxamates.
    Blumberg S; Vogel Z; Altstein M
    Life Sci; 1981 Jan; 28(3):301-6. PubMed ID: 7012516
    [No Abstract]   [Full Text] [Related]  

  • 10. Examination of anthrax lethal factor inhibition by siderophores, small hydroxamates, and protamine.
    Thomas M; Castignetti D
    J Microbiol Immunol Infect; 2009 Aug; 42(4):284-9. PubMed ID: 19949750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of aminopeptidases by N-aminoacyl-O-4-nitrobenzoyl hydroxamates.
    Demuth HU; Stöckel A; Schierhorn A; Fittkau S; Kirschke H; Brömme D
    Biochim Biophys Acta; 1993 Oct; 1202(2):265-70. PubMed ID: 8399389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new class of potent reversible inhibitors of metallo-proteinases: C-terminal thiol-peptides as zinc-coordinating ligands.
    Peters K; Jahreis G; Kotters EM
    J Enzyme Inhib; 2001 Oct; 16(4):339-50. PubMed ID: 11916139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic evidence for cooperative binding of two ortho-phenanthroline molecules to astacus protease during metal removal.
    Wolz RL; Zwilling R
    J Inorg Biochem; 1989 Mar; 35(3):157-67. PubMed ID: 2723627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinetic comparison of the homologous proteases astacin and meprin A.
    Wolz RL
    Arch Biochem Biophys; 1994 Apr; 310(1):144-51. PubMed ID: 8161197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating succinyl hydroxamate and iminodiacetic acid hydroxamate moieties.
    Santos MA; Marques S; Gil M; Tegoni M; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):233-42. PubMed ID: 14506914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-peptidyl-O-carbamoyl amino acid hydroxamates: irreversible inhibitors for the study of the S2' specificity of cysteine proteinases.
    Brömme D; Kirschke H
    FEBS Lett; 1993 May; 322(3):211-4. PubMed ID: 8486151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease inhibitors: synthesis of a series of bacterial collagenase inhibitors of the sulfonyl amino acyl hydroxamate type.
    Clare BW; Scozzafava A; Supuran CT
    J Med Chem; 2001 Jun; 44(13):2253-8. PubMed ID: 11405662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature of papain products resulting from inactivation by a peptidyl O-acyl hydroxamate.
    Ménard R; Feng R; Storer AC; Robinson VJ; Smith RA; Krantz A
    FEBS Lett; 1991 Dec; 295(1-3):27-30. PubMed ID: 1765161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.
    Puerta DT; Lewis JA; Cohen SM
    J Am Chem Soc; 2004 Jul; 126(27):8388-9. PubMed ID: 15237990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refined 1.8 A X-ray crystal structure of astacin, a zinc-endopeptidase from the crayfish Astacus astacus L. Structure determination, refinement, molecular structure and comparison with thermolysin.
    Gomis-Rüth FX; Stöcker W; Huber R; Zwilling R; Bode W
    J Mol Biol; 1993 Feb; 229(4):945-68. PubMed ID: 8445658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.